132 related articles for article (PubMed ID: 20833691)
21. Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial.
Masson S; Aleksova A; Favero C; Staszewsky L; Bernardinangeli M; Belvito C; Cioffi G; Sinagra G; Mazzone C; Bertocchi F; Vago T; Peri G; Cuccovillo I; Masuda N; Barlera S; Mantovani A; Maggioni AP; Franzosi MG; Disertori M; Latini R;
Heart; 2010 Dec; 96(23):1909-14. PubMed ID: 20965978
[TBL] [Abstract][Full Text] [Related]
22. Frequency of elevation of C-reactive protein in atrial fibrillation.
Anderson JL; Allen Maycock CA; Lappé DL; Crandall BG; Horne BD; Bair TL; Morris SR; Li Q; Muhlestein JB;
Am J Cardiol; 2004 Nov; 94(10):1255-9. PubMed ID: 15541240
[TBL] [Abstract][Full Text] [Related]
23. In-hospital outcome of patients with acute coronary syndrome: relationship with inflammation and remodeling markers.
Giansante C; Fiotti N; Di Chiara A; Altamura N; Wasserman S; Fioretti P; Guarnieri G
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):602-7. PubMed ID: 17667031
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and atrial fibrillation: cause or effect?
Boos CJ; Lip GY
Heart; 2008 Feb; 94(2):133-4. PubMed ID: 18195117
[No Abstract] [Full Text] [Related]
25. Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation?
Colkesen Y; Acil T; Abayli B; Yigit F; Katircibasi T; Kocum T; Demircan S; Sezgin A; Ozin B; Muderrisoglu H
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):411-4. PubMed ID: 18600091
[TBL] [Abstract][Full Text] [Related]
26. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation].
Zyśko D; Gajek J; Mazurek W
Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137
[TBL] [Abstract][Full Text] [Related]
27. Prospective assessment of cytokine IL-15 activity in patients with refractory atrial fibrillation episodes.
Borowiec A; Kontny E; Smolis-Bąk E; Kowalik I; Majos E; Załucka L; Plaziński K; Maśliński W; Szwed H; Dabrowski R
Cytokine; 2015 Jul; 74(1):164-70. PubMed ID: 25936571
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".
Acevedo M; Corbalán R; Braun S; Pereira J; Navarrete C; Gonzalez I
Int J Cardiol; 2006 Apr; 108(3):326-31. PubMed ID: 15985301
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein and microalbuminuria are associated with atrial fibrillation.
Asselbergs FW; van den Berg MP; Diercks GF; van Gilst WH; van Veldhuisen DJ
Int J Cardiol; 2005 Jan; 98(1):73-7. PubMed ID: 15676170
[TBL] [Abstract][Full Text] [Related]
30. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans.
Fischer CP; Perstrup LB; Berntsen A; Eskildsen P; Pedersen BK
Clin Immunol; 2005 Nov; 117(2):152-60. PubMed ID: 16112617
[TBL] [Abstract][Full Text] [Related]
31. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.
Rizos I; Tsiodras S; Rigopoulos AG; Dragomanovits S; Kalogeropoulos AS; Papathanasiou S; Sakadakis EA; Kremastinos DT
Cytokine; 2007 Dec; 40(3):157-64. PubMed ID: 17923414
[TBL] [Abstract][Full Text] [Related]
33. Different structural remodelling in atrial fibrillation with different types of mitral valvular diseases.
Qian Y; Meng J; Tang H; Yang G; Deng Y; Wei D; Xiang B; Xiao X
Europace; 2010 Mar; 12(3):371-7. PubMed ID: 20106797
[TBL] [Abstract][Full Text] [Related]
34. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
[TBL] [Abstract][Full Text] [Related]
35. The temporal profile of inflammatory markers and mediators in blood after acute ischemic stroke differs depending on stroke outcome.
Worthmann H; Tryc AB; Goldbecker A; Ma YT; Tountopoulou A; Hahn A; Dengler R; Lichtinghagen R; Weissenborn K
Cerebrovasc Dis; 2010; 30(1):85-92. PubMed ID: 20484906
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation.
Cianfrocca C; Loricchio ML; Pelliccia F; Pasceri V; Auriti A; Bianconi L; Guido V; Rosano G; Mercuro G; Santini M
Int J Cardiol; 2010 Jun; 142(1):22-8. PubMed ID: 19178964
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
Tousoulis D; Zisimos K; Antoniades C; Stefanadi E; Siasos G; Tsioufis C; Papageorgiou N; Vavouranakis E; Vlachopoulos C; Stefanadis C
Int J Cardiol; 2009 Aug; 136(3):258-62. PubMed ID: 18657327
[TBL] [Abstract][Full Text] [Related]
38. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-8 and atrial fibrillation.
Melenovsky V; Lip GY
Europace; 2008 Jul; 10(7):784-5. PubMed ID: 18523030
[No Abstract] [Full Text] [Related]
40. Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?
Tang RB; Dong JZ; Liu XP; Ma CS
Med Hypotheses; 2006; 67(3):462-6. PubMed ID: 16793213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
